Metraipolis › archive › dc_55df4aa9ec74

Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir — Europe PMC PMID:40965470

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40965470
DOI: 10.1128/aac.00614-25
License (as archived): solo-consultazione
Archived: 2026-11-09T21:29:11.678Z
SHA-256 of the archived text: 978df781aac294491edb86ac8b9892ff1518853c662b16c47bbb240d5bf27eb6
Stable URL of this page: https://metraipolis.com/documento/dc_55df4aa9ec74

How to cite

Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir — Europe PMC PMID:40965470 — Europe PMC (en), https://europepmc.org/article/MED/40965470 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_55df4aa9ec74 (Metraipolis archive dc_55df4aa9ec74, sha256 978df781aac294491edb86ac8b9892ff1518853c662b16c47bbb240d5bf27eb6)

BibTeX

@misc{dc55df4aa9ec74,
  title = {Model-informed drug development in public health emergency of international concern: accelerating marketing authorization of simnotrelvir — Europe PMC PMID:40965470},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40965470},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_55df4aa9ec74; sha256 978df781aac294491edb86ac8b9892ff1518853c662b16c47bbb240d5bf27eb6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40965470. Agents can read the archived copy with the MCP tool read_document.